About CRA | Expertise | Consultants | Publications | News | Events | Offices | Careers                                                                         
Take a closer look. When a pharmaceutical product franchise was faced with regulatory pricing
pressure, new competitors, and the entry of biosimilars, they came to CRA. We analyzed their
options, developed a country segmentation strategy, and recommended an optimal reaction to
biosimilar entry scenarios.


CRA’s consultants combine uncommon intellectual acumen with practical experience and in-depth understanding of industries and markets. We are adept at handling tough assignments with pivotal and high-stakes outcomes. Our analytical strength enables us to reach objective, factual conclusions that help our clients make important business and policy decisions and resolve critical disputes.